Search results :

Fluvastatin

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: C10AA04

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13
Gastrointestinal disorder Gastrointestinal disorder 6.3% 4.5% x x x x x
Gastrointestinal symptom NOS x
Angiopathy Angiopathy 5.8% 4.2% x x x x x
Influenza like illness Influenza-like symptoms 5.1% - 7.1% 5.7% x x x x x x x x x x x x x
Blood creatine phosphokinase increased Blood creatine phosphokinase increased common x
Injury Trauma 4.2% - 5.1% 4.8% x x x x x x x x x x x x x
Rhinitis Rhinitis 1.5% - 4.9% x x x x
Headache Headache common, 0.9% - 8.9% 3% - 7.8% x x x x x x x x x x x x x
Nervous system disorder Nervous system disorder 3.9% 3.5% x x x x x
Pharyngitis Pharyngitis 2.4% - 3.8% x x x x
Abdominal pain Abdominal pain common, 0.7% - 4.9% 2% - 3.8% x x x x x x x x x x x x x
Gastrointestinal pain Abdominal pain common, 0.7% - 4.9% 2% - 3.8% x x x x x x x x x x x x x
Dyspepsia Dyspepsia common, 0.3% - 7.9% 2.3% - 3.2% x x x x x x x x x x x x x
Heartburn x
Arthropathy Arthropathy 3.2% x x x x x x x x x x x
Osteoarthritis Arthropathy 3.2% x x x x x x x x x x x
Sinusitis Sinusitis 1.9% - 3.5% 1.9% x x x x x x x x x x x x x
Constipation Constipation 0.8% - 3.3% 2.5% x x x x x x x x
Cough Cough 1.9% - 2.9% x x x x
Infection Infection 2.3% 2% x x x x x x x x x x
Infestation Infestation NOS 2.3% 2% x x x x
Urinary tract infection Urinary tract infection 1.6% - 2.7% 1.1% x x x x x x x x x x x
Connective tissue disorder Connective tissue disorder 2.1% 1.8% x x x x x
Nausea Nausea common, 0.4% - 3.2% 1.4% - 2% x x x x x x x x x x x x x
Flatulence Flatulence 0.8% - 2.6% 2.2% - 2.5% x x x x x x x x x x x x x
Bronchitis Bronchitis 1% - 2.6% 1% x x x x x x x x x x x
Tooth disorder Tooth disorder 1.4% - 2.1% x x x x x x x x
Myalgia Myalgia postmarketing — 1.5% - 5% 2.3% - 4.5% x x x x x x x x x x x x x
Musculoskeletal discomfort Myalgia postmarketing — 1.5% - 5% 2.3% - 4.5% x x x x x x x x x x x x x
Arthralgia postmarketing, 0.2% - 4.1% 1.5% x x x x x x x x x x x x x
Diarrhoea Diarrhoea 0.2% - 4.9% 2.1% - 4.2% x x x x x x x x x x x x x
Asthenia Fatigue 0.2% - 2.7% 1.8% - 2.3% x x x x x x x x x x x x x
Asthenia postmarketing x x x x x x x x x x x x
Fatigue Fatigue 0.2% - 2.7% 1.8% - 2.3% x x x x x x x x x x x x x
Upper respiratory tract infection Upper respiratory tract infection 0.2% - 16.5% 1.9% x x x
Visual impairment Abnormal vision 0% - 1.1% 1.4% x
Back pain Back pain 0.4% - 1.1% 1.6% x x x x
Arthritis Arthritis postmarketing, 1.3% - 2.1% 2% x x x x x x x x x x x x x
Eructation Eructation 0% - 1.4% 1.1% x
Dizziness Dizziness postmarketing, 0.5% - 2.5% 1.8% - 2.5% x x x x x x x x x x x x x
Syncope x x x x
Chest pain Chest pain 0.2% - 1.4% 0.5% x x x
Abdominal pain upper Abdominal pain upper 0.3% x x x x
Insomnia Insomnia postmarketing — 0.2% - 2.7% 0.9% - 1.4% x x x x x x x x x x x x x
Dermatitis Rash postmarketing — 0.2% - 1.9% 1.6% x x x x x x x x
Dermatitis postmarketing x x x x x x
Rash Rash postmarketing — 0.2% - 1.9% 1.6% x x x x x x x x
Alopecia Alopecia postmarketing x x x x x x x x x x x x
Amnesia Amnesia postmarketing x x x x
Memory loss postmarketing x x x x x x x x x x x
Anaphylactic shock Anaphylactic shock very rare, postmarketing x x x x x x x x x x x x x
Haemolytic anaemia Haemolytic anaemia postmarketing x x x x x x x x x x x x
Angioedema Angioedema postmarketing x x x x x x x x x x x x x
Decreased appetite Anorexia postmarketing x x x x x x x x x x x x
Anxiety Anxiety postmarketing x x x x x x x x x x x x
Arthralgia Arthralgia postmarketing, 0.2% - 4.1% 1.5% x x x x x x x x x x x x x
Confusional state Confusional state postmarketing x x x x
Feeling abnormal Confusional state postmarketing x x x x
Malaise postmarketing x x x x x x x x x x x x
Dysgeusia Dysgeusia postmarketing x x x x x x x x x x x
Dyspnoea Dyspnoea postmarketing x x x x x x x x x x x x
Eczema Eczema postmarketing x x x x x x
Eosinophilia Eosinophilia postmarketing x x x x x x x x x x x
Toxic epidermal necrolysis Toxic epidermal necrolysis postmarketing x x x x x x x x x x x x
Erythema multiforme Erythema multiforme postmarketing x x x x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x
Body temperature increased Body temperature increased postmarketing x x x x x x x x x x x x
Flushing Flushing postmarketing x x x x x x x x x x x x
Gynaecomastia Gynaecomastia postmarketing x x x x x x x x x x x x
Hepatitis Hepatitis very rare, postmarketing x x x x x x x x x x x x x
Hypersensitivity Hypersensitivity postmarketing — 1% - 2.3% 2.2% x x x x x x x x x x x x x
Hypoaesthesia Hypoaesthesia very rare, postmarketing x x x x x x
Jaundice cholestatic Jaundice cholestatic postmarketing x x x x x x x x x x x x
Leukopenia Leukopenia postmarketing x x x x x x x x x x x x
Muscle spasms Cramp muscle postmarketing x x x x x x x x x x x x
Muscle spasms postmarketing x x x x
Myopathy Myopathy postmarketing, rare x x x x x x x x x x x x x
Myositis Myositis very rare, postmarketing x x x x x x
Nodule Nodule postmarketing x x x x x x x x x x x
IIIrd nerve paralysis Ophthalmoplegia postmarketing x x x x x x x x x x x
Ophthalmoplegia Ophthalmoplegia postmarketing x x x x x x x x x x x
Pancreatitis Pancreatitis very rare, postmarketing x x x x x x x x x x x x x
Paraesthesia Paraesthesia very rare, postmarketing x x x x x x x x x x x x x
Neuropathy peripheral Neuropathy peripheral postmarketing x x x x x x x x x x x x
Polymyalgia rheumatica Polymyalgia rheumatica postmarketing x x x x x x x x x x x x
Pruritus Pruritus postmarketing x x x x x x x x x x x x
Purpura Purpura postmarketing x x x x x x x x x x x x
Vascular purpura Purpura postmarketing x x x x x x x x x x x x
Rhabdomyolysis Rhabdomyolysis very rare, postmarketing x x x x x x x x x x x x x
Stevens-Johnson syndrome Stevens-Johnson syndrome postmarketing x x x x x x x x x x x x
Thrombocytopenia Thrombocytopenia very rare, postmarketing x x x x x x x x x x x x x
Tremor Tremor postmarketing x x x x x x x x x x x
Urticaria Urticaria postmarketing, rare x x x x x x x x x x x x x
Vasculitis Vasculitis very rare, postmarketing x x x x x x x x x x x x x
Vertigo Vertigo postmarketing x x x x x x x x x x x
Vomiting Vomiting postmarketing x x x x x x x x x x x x
Chills Chills postmarketing x x x x x x x x x x x x
Hepatic failure Hepatic failure postmarketing x x x x
Dermatitis bullous Dermatitis bullous postmarketing x x x x
Cataract Cataract postmarketing x x x x x x x x x x x
Antinuclear antibody positive Antinuclear antibody positive postmarketing x x x x x x x x x x x x
Muscular weakness Muscular weakness postmarketing, rare x x x x x x
Hepatic necrosis Hepatic necrosis postmarketing x x x x x x x x x x x
Photosensitivity reaction Photosensitivity reaction postmarketing x x x x
Photosensitivity x x x x x x x x
Malaise Malaise postmarketing x x x x x x x x x x x x
Discomfort Malaise postmarketing x x x x x x x x x x x x
Ill-defined disorder Malaise postmarketing x x x x x x x x x x x x
Memory impairment Memory impairment postmarketing x x x x
Forgetfulness postmarketing x x x x
Erectile dysfunction Erectile dysfunction postmarketing x x x x x x x x x x x x
Cognitive disorder Cognitive impairment postmarketing x x x x
Dysaesthesia Dysaesthesia very rare, postmarketing x x x x x x
Systemic lupus erythematosus Lupus erythematosus very rare, postmarketing x x x x x x x x x x x x x
Facial paresis Facial paresis postmarketing x x x x x x x x x x x
VIIth nerve paralysis Facial paresis postmarketing x x x x x x x x x x x
Transaminases increased Transaminases increased postmarketing, common x x x x x x x x x x x x
Hepatitis chronic active Hepatitis chronic active postmarketing x x x x x x x x x x x
Drug reaction with eosinophilia and systemic symptoms Hypersensitive syndrome postmarketing x x x x x x x x x x x x
Peripheral nerve palsy Peripheral nerve palsy postmarketing x x x x x x x x x x x
Lenticular opacities Lenticular opacities postmarketing x x x x x x x x x x x
Hepatic cancer Hepatocellular carcinoma postmarketing x x x x x x x x x x x
Hepatocellular carcinoma Hepatocellular carcinoma postmarketing x x x x x x x x x x x
Loss of libido Loss of libido postmarketing x x x x x x x x x x x
Immune-mediated necrotising myopathy Immune-mediated necrotising myopathy postmarketing x x x
Pancreatitis acute Pancreatitis acute x
Arrhythmia Arrhythmia x
Atrial fibrillation Atrial fibrillation x x x x
Mental disorder Mental disorder 1.4% x x x x x x x x
Breast disorder Breast disorder x
Conjunctivitis Conjunctivitis x
Gastritis Gastritis x
Cardiac disorder Cardiac disorder x x x x
Hypertension Hypertension x x x x
Immune system disorder Immune system disorder x
Influenza Influenza x x x x x
Intermittent claudication Intermittent claudication x x x x
Renal failure acute Renal failure acute x x x x x x x x x x x x
Pain in extremity Leg pain x
Pain in extremity x x x x
Myoglobinuria Myoglobinuria x x x x x
Myoglobin urine present Myoglobinuria x x x x x
Nasopharyngitis Nasopharyngitis x x x x
Pain Pain x
Gastric disorder Gastric disorder x x x x
Hyperhidrosis Sweating x
Shock Syncope x x x x
Syncope Syncope x x x x
Loss of consciousness Syncope x x x x
Erythema Erythema x
Oedema peripheral Oedema peripheral x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Dyspnoea exertional Dyspnoea exertional x x x x
Tenderness Tenderness x
Hepatobiliary disease Hepatobiliary disease x
Muscle swelling Muscle swelling x
Face oedema Face oedema x x
Menopausal symptoms Hot flush x
Hot flush Hot flush x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

FLUVASTATIN (FLUVASTATIN SODIUM) / LESCOL 20MG

Side effects:81
Source:Health Canada

fluvastatin sodium / Lescol

Side effects:74
Source:FDA

FLUVASTATIN SODIUM / LESCOL

Side effects:74
Source:FDA

fluvastatin sodium / Lescol

Side effects:76
Source:FDA

FLUVASTATIN

Side effects:76
Source:FDA Structured Product Label

FLUVASTATIN SODIUM / LESCOL

Side effects:76
Source:FDA

FLUVASTATIN SODIUM / LESCOL

Side effects:82
Source:FDA

FLUVASTATIN SODIUM / LESCOL

Side effects:82
Source:FDA

FLUVASTATIN

Side effects:109
Source:FDA Structured Product Label

FLUVASTATIN

Side effects:109
Source:FDA Structured Product Label

FLUVASTATIN

Side effects:109
Source:FDA Structured Product Label

FLUVASTATIN

Side effects:110
Source:FDA Structured Product Label

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label